Cargando…

VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma

Clear cell Renal Cell Carcinoma (ccRCC) formation is connected to functional loss of the von Hippel-Lindau (VHL) gene. Recent data identified its gene product, pVHL, as a multifunctional adaptor protein which interacts with HIFα subunits but also with the tumor suppressor p53. p53 is hardly expresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razafinjatovo, Caroline Fanja, Stiehl, Daniel, Deininger, Eva, Rechsteiner, Markus, Moch, Holger, Schraml, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354652/ https://www.ncbi.nlm.nih.gov/pubmed/28052007 http://dx.doi.org/10.18632/oncotarget.14372

Ejemplares similares

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice
por: Harlander, Sabine, et al.
Publicado: (2017)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013)

Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
por: Abd-Aziz, Noraini, et al.
Publicado: (2016)

wPrognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear-cell renal cell carcinoma treated with sunitinib as first-line treatment
por: Wierzbicki, Piotr M., et al.
Publicado: (2019)

Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway
por: Stransky, Laura A., et al.
Publicado: (2022)

p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma
por: Rodrigues, Joana M., et al.
Publicado: (2020)

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022)

HIF-transcribed p53 chaperones HIF-1α
por: Madan, Esha, et al.
Publicado: (2019)

Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system
por: Ni, Jieming, et al.
Publicado: (2021)

Structural and functional implications of p53 missense cancer mutations
por: Tan, Yuhong, et al.
Publicado: (2009)

Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
por: Li, Mingqing, et al.
Publicado: (2011)

IL‐8 and CXCR1 expression is associated with cancer stem cell‐like properties of clear cell renal cancer
por: Corrò, Claudia, et al.
Publicado: (2019)

Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)

EC(5)S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors
por: Cai, Qi-Liang, et al.
Publicado: (2006)

The up‐regulation of NDRG1 by HIF counteracts the cancer‐promoting effect of HIF in VHL‐deficient clear cell renal cell carcinoma
por: Zhang, Zheng‐Yan, et al.
Publicado: (2020)

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma
por: Gossage, Lucy, et al.
Publicado: (2014)

Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53
por: Szybka, M, et al.
Publicado: (2008)

PRIMA‐1 induces p53‐mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation
por: Furukawa, Haruna, et al.
Publicado: (2017)

p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans
por: Wild, Peter J, et al.
Publicado: (2012)

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
por: Fan, Yang, et al.
Publicado: (2016)

Characterization on the oncogenic effect of the missense mutations of p53 via machine learning
por: Pan, Qisheng, et al.
Publicado: (2023)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
por: Mazumder, Sonia, et al.
Publicado: (2023)

Updates on p53: modulation of p53 degradation as a therapeutic approach
por: Dey, A, et al.
Publicado: (2008)

Modeling the interplay between the HIF-1 and p53 pathways in hypoxia
por: Zhou, Chun-Hong, et al.
Publicado: (2015)

HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation
por: Nardinocchi, Lavinia, et al.
Publicado: (2011)

Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

Activating p53 in Cancer Cells with Protein Therapy Shows Preclinical Promise
Publicado: (2004)

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
por: Kondo, Keiichi, et al.
Publicado: (2003)

Inhibition of HIF2α Protein Suppresses pVHL-Driven Tumor Growth
Publicado: (2003)

Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
por: Gad, Sophie, et al.
Publicado: (2021)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Beluga whale pVHL enhances HIF-2α activity via inducing HIF-2α proteasomal degradation under hypoxia
por: Bi, Jianling, et al.
Publicado: (2017)

cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer
por: Szybka, Malgorzata, et al.
Publicado: (2009)

Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells
por: Wolf, Christopher, et al.
Publicado: (2022)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018)

p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53
por: Forget, Karolyn J., et al.
Publicado: (2013)

VHL and Hypoxia Signaling: Beyond HIF in Cancer
por: Zhang, Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t5t6h884co61d9moi304us8uj2